-
1 . Academic Journal
Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study
- 저자
- by Heppner, DG; Kemp, TL; Martin, BK; Ramsey, WJ; Nichols, R, et al.
- 소스
- In The Lancet Infectious Diseases August 2017 17(8):854-866